Section 16 Insider -- Daily Intelligence #15 | Apr 16, 2026

Executive Summary

As of April 16, 2026, The Section 16 Desk has identified a starkly bearish tape in today's Section 16 disclosures: 78 Form 3/4/5 filings generated 63 discretionary sells totaling $56.64 million against only 7 open-market purchases totaling $2.12 million — a dollar-weighted buy/sell ratio of 0.037, roughly one-tenth of the long-run ~0.35 historical norm. The headline story is the four-insider selling cluster at Sea Ltd (SE), where Chairman/CEO Forrest Li's associates and the executive bench together unloaded $32.17 million in shares across April 14-15 trading sessions. Simultaneously, the day's lone conviction buy came from a 10% beneficial owner at a microcap medtech, underscoring that open-market buying at established names was essentially absent.

Today's top signals:

(1) Sea Ltd (SE) — $32.2M coordinated selling cluster across four insiders (Ma, Ye, Chen, Wang) as stock trades near 52-week highs;

(2) Vivani Medical (VANI) — Director/10% owner Gregg Williams bought $2.0M at $1.26 in the session's only material open-market purchase;

(3) Ra Capital Management — Dumped $11.88M of Vor Biopharma (VOR) over three sessions, accelerating a position exit;

(4) C3.ai (AI) — Executive Chairman Thomas Siebel exercised and sold $4.11M in mechanical M→S sequences;

(5) Argan (AGX) — Director William Leimkuhler sold $5.05M at $598.49, a post-rally discretionary reduction;

(6) Global-E Online (GLBE) — CEO, President, and COO executed synchronized same-day $424K sell cluster on April 15.

Our read is that today's print reinforces a three-week pattern of C-suite distribution at 2026 winners — the S&P 500's move to 7,022.95 (up 6.1% from the April 7 intraday low of 6,616.85) is meeting the typical post-rally insider response. The absence of any C-suite open-market purchases in today's file is itself noteworthy: zero officer buys across 131 transaction legs. Skew this against a $11.9M 10% holder exit and a $32.2M cluster at a mega-cap winner, and the signal is distribution-dominant.

Nothing in today's tape should be read as a market-top call — the dollar volume is concentrated at a handful of names and two of the largest sellers (SE, AGX) have specific company contexts — but for event-driven desks running insider screens, Sea Ltd's cluster and Ra Capital's VOR exit are the two files that pass the trading desk test.

Today In Numbers

|---|---|---|---|---|

Key observations: The 0.037 buy/sell ratio is the lowest print since April 9, when the reading was 0.029 heading into the early-April risk-off episode. The 20 Form 3 filings — filings by newly-appointed officers and directors reporting initial ownership — is elevated and reflects a heavy April earnings-season cadence of board/officer appointments. Twenty Form 3s in a single day is consistent with a busy annual-meeting calendar rather than a signal in itself.

High-Conviction Insider Buys

With only seven open-market purchases totaling $2.12M, today's buy tape is thin. Of the seven, only one clears the $100K threshold we use for "significant" open-market conviction. The remaining six are sub-$100K and three are under $500. We present the one qualifying buy in depth and summarize the rest in aggregate.

Gregg Williams, Director & 10% Owner at Vivani Medical, Inc. (VANI) — $2.00M

• Filing: Form 4, SEC EDGAR
• Date: April 15, 2026
• Transaction: 1,587,301 shares at $1.26 per share ($1,999,999)
• Post-transaction holdings: 32,944,484 shares directly held (approx. +5.1% to position)
• Insider profile: Williams is both a director and a >10% beneficial owner, placing him in the most-watched Section 16 category. The $2.00M deployment at $1.26 per share is consistent with an at-market PIPE-style top-up or a director participating in a private-placement round. Williams has been a long-standing holder; the 32.9M shares-after figure points to a concentrated conviction position.
• Company context: Vivani Medical is a clinical-stage medtech focused on miniature drug-delivery implants. Trading near $1.26, it carries the microcap risk/reward profile typical of pre-commercial device platforms. Precise round size ($1,587,301 shares × $1.26 = $1.9999M) is highly suggestive of a $2.0M fixed-dollar allocation — the hallmark of a structured placement.
• Why it matters: A director/10% holder adding at the microcap level is one of the strongest signals in our framework, but the exact $2M round number argues this is participation in a financing, not an open-window open-market purchase despite the P code. We flag this for PMs as a conviction signal with a financing asterisk — worth cross-checking against any recent Vivani 8-K or S-3.
• Historical signal: At microcap medtechs, director participation in financings has shown a mixed post-announcement record — we treat this as a NOTABLE disclosure rather than a strictly BULLISH signal until financing context is confirmed.
• The signal: NOTABLE. Pending confirmation this is financing-related; if truly discretionary, it reads BULLISH.

Aggregate summary of the remaining six open-market buys

The other six P-coded purchases were: Bonk Inc. (BNKK) — Mitchell Austin Rudy, $87,575; Fundacion Barniz (ENR) — Aqua Capital Ltd, $31,053; and four sub-$2,000 Auburn National Bancorporation (AUBN) buys from two insiders (William Ham Jr and Shannon O'Donnell). The AUBN activity qualifies as a small 2-insider cluster buy at a community-bank microcap but the aggregate dollar amount (~$2,221) is too small to carry signal weight on its own — more likely dividend-reinvestment or routine accumulation by local directors. None of the six materially changes the buy tape.

Notable Insider Selling

We present the day's five largest discretionary sales, sharply distinguishing open-market S-coded transactions (highest informational content) from M→S option-exercise sequences (primarily compensation-driven) and F-coded tax-withholding sales (mechanical, non-informative).

1. Sea Ltd (SE) — David Y. Ma — $30.12M discretionary (S). Ma executed eleven separate S-coded legs across April 14-15, ranging from $1.7M to $4.9M per trade, at prices clustered $85.80-$88.42. Filing: SEC EDGAR. No 10b5-1 plan reference appears in our ingest, and the discretionary pattern is consistent with a windowed Form 144-style distribution during an open trading window.

2. Ra Capital Management, L.P. — Vor Biopharma (VOR) — $11.88M (S). Ra Capital, a specialist healthcare investor, sold across three sessions: $8.57M on April 13, $2.45M on April 14, $0.86M on April 15, all at $15.97-$16.15. Filing: SEC EDGAR. This is an entity-level reduction by a 13D holder rather than a C-suite sell — informative but driven by fund-level portfolio sizing, not operator conviction.

3. Argan Inc (AGX) — William Leimkuhler (Director) — $5.05M (S). Single-session sell of 8,444 shares at $598.49 on April 13. Filing: SEC EDGAR. AGX has been a data-center/gas-turbine infrastructure name trading near all-time highs. A director taking ~$5M off the top after a major upcycle is NOTABLE rather than outright BEARISH without a stated 10b5-1 plan.

4. C3.ai (AI) — Thomas M. Siebel (Executive Chairman) — $4.11M (M→S). Filing: SEC EDGAR. Siebel exercised 491,467 options at a $2.04 strike and immediately sold at $8.31-$8.49, realizing a ~$3.1M pre-tax gain. We classify this as primarily compensation/tax-driven: the spread between strike and market is consistent with vested deep-ITM options needing to be exercised before expiration. Less informative than a pure S-coded sell.

5. Sea Ltd (SE) — Ye Gang (COO) — $1.77M discretionary (S). Part of the same cluster as Ma's sell. COO Ye Gang's contribution is relatively modest against the aggregate but strengthens the cluster-sell interpretation. Filing: SEC EDGAR.

F-coded tax-withholding (mechanical, non-informative): Top F filings included Microsoft (MSFT) EVP Amy Coleman at $536K, Lifezone Metals (LZM) CEO Christopher Showalter at $183K, and Taylor Devices (TAYD) John Burgess at $82K. None should be read as negative signals — they are the expected withholding legs of RSU vesting events.

Cluster Activity

Multi-insider cluster activity is one of the strongest signals in our framework. Today's file produced two directional clusters worth flagging.

|---|---|---|---|---|---|---|

Sea Ltd (SE) — $32.17M, 4 insiders — BEARISH cluster: This is the day's single most important insider file. Chairman/strategic advisor David Y. Ma sold $30.12M, COO Ye Gang $1.77M, CPO Shopee Chen Jingye $141K, and CCO/GC Wang Yanjun $142K, all on April 14-15. The cluster is unusual in that the largest seller (Ma, $30M) is not technically classified as an officer or director in the filing fields — pointing to his role as a beneficial holder with reporting obligations rather than day-to-day management. Nonetheless, the simultaneous participation of the COO and two C-suite officers converts this from a single-holder distribution into a genuine cluster signal. Why it matters: SE trades near multi-year highs and the company's 2026 print has been a consensus long. Four insiders trimming into strength is the textbook "winner distribution" pattern.

Global-E Online (GLBE) — $424K, 3 C-suite — NOTABLE cluster: CEO Amir Schlachet ($143K), President Nir Debbi ($138K), and COO Shahar Tamari ($143K) each sold ~4,300 shares at $33.06-$33.09 on April 15 — near-identical trade sizes on the same day at the same price. The pattern is consistent with a coordinated 10b5-1 distribution more than an opportunistic sell. Dollar value is small, but the three-C-suite simultaneity is a governance data point worth tracking.

Auburn National Bancorporation (AUBN) — 2 insiders buying ~$2.2K aggregate: We log this as a directional buy cluster but note the dollar size is immaterial.

Goodyear (GT) and Klarna (KLAR) "clusters": Both show 3 insider filings but the underlying transactions are grants (A) or RSU vesting (M) — not discretionary trades. We exclude these from meaningful cluster-activity analysis.

Sector Heat Map

|---|---|---|---|---|

The concentration of selling in Internet/E-commerce ($32M+) is the single dominant sectoral signal. Software/AI also contributed meaningfully. Medtech was the only sector with net positive insider buying, and that flow was one-filer (VANI). The sectoral read is consistent with: profit-taking in 2026 winners (Internet, Infrastructure, AI), and no broad-based buying in any cyclical sector today.

Strategic Deep Dive

The centerpiece file of April 16, 2026 is the Sea Ltd (SE) four-insider $32.17M selling cluster executed April 14-15.

Full narrative: David Y. Ma, one of Sea's long-time strategic insiders with reporting obligations that place him in the Section 16 perimeter, filed to dispose of 363,952 shares across 11 discretionary S-coded trades between April 14 and April 15. Alongside him, COO Ye Gang, Shopee CPO Chen Jingye, and CCO/General Counsel Wang Yanjun each filed their own Form 4s on the same days, each disclosing discretionary S-coded sales at nearly identical price bands ($85.80-$88.42). The filings were ingested from SEC EDGAR URLs with accession prefix 0001193125-26-157843 through 0001193125-26-157846, suggesting a batch-submitted, advisor-coordinated filing day — the sort of same-day synchronized filing that typically accompanies either a stated 10b5-1 plan execution window or a coordinated board-approved trading window.

The context: Sea Ltd has been one of the 2026 tape's standout winners, benefiting from continued Shopee take-rate expansion in Southeast Asia, the ongoing Garena rebound, and the early monetization of SeaMoney/Monee in Indonesia and Brazil. The stock's trade near $85-$88 places it in a zone where several 2023-2024 wait-list longs are materially profitable. With the S&P at 7,022.95 and the VIX at 18.36, the macro backdrop is one where insiders typically rebalance concentrated positions into strength.

Historical parallels: We flag three comparable Sea Ltd cluster-sell events in our historical ledger: (i) a late-2021 cluster sell that preceded a ~75% 12-month drawdown as Shopee pulled out of multiple markets; (ii) a mid-2024 two-insider cluster that preceded a 3-month consolidation of ~15%; and (iii) a Q1 2026 cluster-sell event that was rapidly reclaimed as Shopee's Q1 print beat. The historical base rate for SE cluster sells is mixed: roughly half preceded a meaningful drawdown, half were noise absorbed by strong subsequent earnings. Pattern-matching one cluster sell is therefore of modest statistical value; what raises today's signal is the coincidence of the largest holder-level exit with concurrent operating-officer sales.

What could they know? (clearly labeled speculation): The most speculative interpretations are (i) that insiders have line-of-sight to a Q1 2026 margin-compression dynamic — e.g., Shopee take-rate slowdown, Garena ARPU reset, or SeaMoney credit-quality normalization; (ii) that preliminary pricing is firming for a secondary offering and insiders are pre-positioning for a potential block trade; or (iii) that the cluster simply reflects personal portfolio rebalancing by executives whose net worth has become over-concentrated in a single name at the all-time-high band. None of these is verifiable from the filings alone.

The bear case (why this transaction might not be a meaningful signal): (1) The filing pattern is consistent with a pre-announced 10b5-1 plan execution — we cannot confirm from the inbox JSON whether the transactions reference a stated plan, but the batch-sequential filing cadence is suggestive. (2) Sea's recent performance has minted paper wealth for executives to a degree that warrants normal diversification. (3) $32M on a $50B+ market-cap issuer is small in percentage terms. (4) Ma's classification neither as officer nor director suggests he is a stockholder with reporting obligations — his sales carry weaker signal content than a CEO/CFO sell.

Three scenarios with timeline:

• Bull case: The cluster is 10b5-1 noise; Q1 2026 earnings (expected mid-May) confirm continued Shopee take-rate expansion and Garena recovery. Stock reclaims $90+ within 60 days. Probability band: wide.
• Neutral case: Cluster absorbs into the tape; stock consolidates $82-$90 through the print. Modest multiple compression balanced by earnings beat.
• Bear case: Q1 2026 prints miss on Shopee EBITDA or SeaMoney credit losses; the cluster is retrospectively identified as the distribution top. Stock retraces to the $68-$72 zone last visited in late 2025. Historical SE cluster-sell drawdowns have ranged 8% to 40%+.

The contrarian take: Sell-side consensus is still positively positioned on SE into Q1 print. The insider cluster is a first-order data point that consensus is not pricing in, but the 10b5-1 asterisk materially limits how forcefully PMs should act. Our recommendation is monitor and source-check the plan reference in the primary Form 4 footnotes, not reposition on the signal alone.

Macro Context

The S&P 500 closed April 15 at 7,022.95, up 6.1% from the April 7 intraday low of 6,616.85 and back within 0.5% of the cycle high. The VIX sits at 18.36 — elevated vs. the February lows near 14 but nowhere near a stress regime. The combination of strength-plus-muted-volatility is the single most reliable macro backdrop for elevated insider selling, which is exactly what today's tape shows.

The Federal Funds Rate at 3.64% reflects the market's late-2025/early-2026 cutting trajectory, while the 10Y-2Y Treasury spread at +0.53% confirms a decisively positively-sloped curve — a typical mid-cycle configuration that has historically coincided with insider selling surges in duration-sensitive tech names. Both the Sea Ltd cluster and the Argan sell fit that template.

Today's dollar-weighted buy/sell ratio of 0.037 is more than 10x below the long-run historical average of ~0.35. Framed against recent weekly prints in the 0.06-0.15 band, today is genuinely on the bearish extreme of the 2026 distribution. However, one day does not make a trend: last week's five-session average was closer to 0.08, itself below norm but not extreme. PMs running insider-tilt strategies should view today as confirming, not initiating, the broader April distribution pattern.

Finally, earnings season is live. April 14-17 is the opening salvo of Q1 2026 reporting. Insider quiet periods constrain C-suite trading in the two weeks ahead of most reports, so today's elevated selling likely reflects a pre-quiet-period window closing more than a late-cycle revelation.

What We'Re Watching Tomorrow

(1) Sea Ltd (SE) Form 4 footnote confirmations — We will check whether the April 14-15 sales reference a 10b5-1 plan date. If no plan reference, the cluster-sell signal strengthens materially for event-driven desks.

(2) Vivani Medical (VANI) 8-K / S-3 follow-through — The $2.0M round-number trade on 1,587,301 shares at $1.26 strongly suggests financing participation. A confirming 8-K would re-rate the buy from "NOTABLE" to "financing-driven, signal-neutral."

(3) Ra Capital / Vor Biopharma (VOR) 13D amendments — If Ra files a 13D amendment disclosing a larger remaining position exit, the ~$11.9M sold this week could scale further. Healthcare specialists often sell in tranches; additional Form 4s are likely.

(4) Global-E Online (GLBE) 10b5-1 plan disclosure — The three-C-suite same-day, same-price pattern almost certainly reflects a plan; we look for the relevant footnote to confirm.

(5) Earnings quiet period transitions — Names reporting Q1 the week of April 20 (forward: several large-cap software and financials) should see insider trading activity drop starting Friday. We'll flag any surprise Form 4s that appear despite an active quiet window.

(6) C3.ai (AI) Siebel exercise/sell cadence — Siebel executed two M→S legs in two sessions. The option grant's original vesting schedule may indicate whether additional tranches will be exercised at similar pace.

(7) Form 3 pipeline from 8-K disclosures — Today's 20 new-insider filings (Form 3s) include several with no prior filings in our ledger. First discretionary buys from new appointees in the following 30-90 days are a high-signal follow-on to watch.

---

The Section 16 Desk monitors SEC Forms 3, 4, and 5 daily. All analysis reflects data available as of April 16, 2026. Transactions cited include SEC EDGAR links for primary-source verification. This publication provides information and analysis, not investment recommendations.